CBL anticorps (pTyr770)
Aperçu rapide pour CBL anticorps (pTyr770) (ABIN2135027)
Antigène
Voir toutes CBL AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- pTyr770
-
Purification
- c-Cbl antibody was purified by immunoaffinity chromatography.
-
Immunogène
- c-Cbl antibody was raised in Rabbit using the peptide sequence around phosphorylation site of Tyr770 (T-E-Y(p)-M-T) derived from Human c-Cbl as the immunogen.
-
-
-
-
Indications d'application
- IF: 1:100-1:200, IHC: 1:50-1:100, WB: 1:500-1:1000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- In liquid form PBS buffer (no MG2+ or Ca2+), pH 7.4, 150 mm NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles
-
Stock
- -20 °C
-
Stockage commentaire
- Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.
-
-
- CBL (Cas-Br-M (Murine) Ecotropic Retroviral Transforming Sequence (CBL))
-
Autre désignation
- C-Cbl
-
Pathways
- TCR Signaling, Interferon-gamma Pathway, EGFR Signaling Pathway, EGFR Downregulation, VEGFR1 Specific Signals
Antigène
-